Pneumonitis with 60-72 Gy at 4 Gy

Editor-in-Chief, Robert Amdur, MD, discusses a paper from the March 2024 issue of PRO: "Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy" (Volume 14 Issue 2, PMID 37984711). This paper suggests V5, V20, and Mean Lung Dose values to minimize grade ≥2 pneumonitis when treating lung cancer with the moderate hypofractionation programs of 60 or 72 Gy at 4 Gy per treatment. The values they propose are lower than those stated in consensus group guidelines.

Om Podcasten

Stay current with the latest studies in radiation oncology with free podcasts from the official journals of the American Society for Radiation Oncology (ASTRO). The International Journal of Radiation Oncology-Biology-Physics (the Red Journal) publishes the latest clinical research related to radiation oncology, radiation biology, medical physics, education, and health policy. The overarching mission of Practical Radiation Oncology is to improve the quality of radiation oncology practice through publication of official ASTRO guidelines and white papers, discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. Advances in Radiation Oncology is a wide-ranging clinical research journal whose articles are free and open for all to read. Visit www.redjournal.org, www.practicalradonc.org, and www.advancesradonc.org to learn more about ASTRO's journals.